Evidence map›Paper›PMID 30385855›Full record

ArticleMucosal immunology2019

Correction: E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.

P J Sarate, S Heinl, S Poiret, M Drinić, C Zwicker, I Schabussova, C Daniel, U Wiedermann

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Mucosal immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

P J SarateInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
S HeinlDepartment of Biotechnology, University of Natural Resources and Life Sciences VIBT, Vienna, Austria.
S PoiretUniv. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France.
M DrinićInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
C ZwickerInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
I SchabussovaInstitute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria.
C Daniel *Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-Centre d'Infection et d'Immunité de Lille, 59000, Lille, France. catherine.daniel@ibl.cnrs.fr.
U Wiedermann *Institute of Specific Prophylaxis and Tropical Medicine, Medical University of Vienna, Vienna, Austria. ursula.wiedermann@meduniwien.ac.at.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this article, the authors have requested that the Acknowledgements section be amended to include the financing source of the study. The correct Acknowledgments should be as follows: We gratefully acknowledge funding from the Austrian Science Fund SFB F46 and DK MCCA W1248-B30, OeAD-GmbH grants (FR13/2016) and from the Amadeus partnership Hubert Curein French and Austrian program. We thank the BioImaging Center of Lille (Frank Lafont) for the use of the IVIS Lumina XR. We gratefully thank Katharina Ambroz, Elke Korb, Karin Baier, Erika Garner-Spitzer, Joshua Tobias, Gwenaëlle Verbrugghe, and Jéremy Desramaut for their technical assistance and helpful discussions.

Identifiers

PMID30385855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.